Indeed, deleterious CNVs in cancer patients have been observed in more than 30% of highly penetrant cancer-predisposing genes, including BRCA1, BRCA2, APC, as well as mismatch repair (MMR) genes [7, 8]. The gene discussed is BRCA2; the disease is cancer.